如何灵活使用组织 cDNA 芯片

现在推出活动，组织 cDNA 芯片系列产品的 qPCR，只收取实验费用，免芯片费！！！

什么是组织 cDNA 芯片
组织 cDNA 芯片是一个包含肿瘤和癌旁组织 cDNA 的阵列，可以直接用于实时荧光定量 PCR，检测目的基因
（包括 mRNA、microRNA、circRNA 和 lncRNA）在不同样本中的表达。现有产品涵盖肺癌、食管癌、胃癌、结肠癌和肝癌。

组织 cDNA 芯片的优势

• 无需收集样本  
• 无需抽提、反转录

• 样本具有详细的
• 临床随访信息

• 严格质控，高质量 RNA
• 看家基因 Actin 水平验证

• 配套的石蜡样本组织芯片
• 帮助实现基因、蛋白水平双重验证

2、结合临床参数，分析临床相关性



3、进行生存分析



组织 cDNA 产品列表



组织 cDNA 芯片参考文献
1. Lehtinen L, Vainio P, Wikman H, Huhtala H, Mueller V, Kallioniemi A, Pantel K, Kronqvist P, Kallioniemi O, Carpen O et al: PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells. The journal of pathology Clinical research 2017, 3(2):123-138.
2. Lin KT, Yeh YM, Chuang CM, Yang SY, Chang JW, Sun SP, Wang YS, Chao KC, Wang LH: Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B. Nature communications 2015, 6:5917.
3. Viphakone N, Cumberbatch MG, Livingstone MJ, Heath PR, Dickman MJ, Catto JW, Wilson SA: Luzp4 defines a new mRNA export pathway in cancer cells. Nucleic acids research 2015, 43(4):2353-2366.
4. Kim Y, Kim J, Jang SW, Ko J: The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer. Oncogene 2015, 34(2):226-236.
5. Hollander L, Guo X, Velazquez H, Chang J, Safirstein R, Kluger H, Cha C, Desir GV: Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism. Cancer research 2016, 76(13):3884-3894.
6. Young HL, Rowling EJ, Bugatti M, Giurisato E, Luheshi N, Arozarena I, Acosta JC, Kamarashev J, Frederick DT, Cooper ZA et al: An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition. The Journal of experimental medicine 2017, 214(6):1691-1710.
7. Blake A, Dragan M, Tirona RG, Hardy DB, Brackstone M, Tuck AB, Babwah AV, Bhattacharya M: G protein-coupled KISS1 receptor is overexpressed in triple negative breast cancer and promotes drug resistance. Scientific reports 2017, 7:46525.
8. Tseng HY, Chen YA, Jen J, Shen PC, Chen LM, Lin TD, Wang YC, Hsu HL: Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression. Oncogenesis 2017, 6(4):e313.